Combination product comprising melagatran and factor VIIa inhibitor
First Claim
Patent Images
1. A combination product comprising:
- (A) melagatran or a pharmaceutically-acceptable derivative thereof; and
(B) a Factor VIIa inhibitor or a pharmaceutically-acceptable derivative thereof, wherein each of components (A) and (B) is formulated in admixture with a pharmaceutically-acceptable adjuvant, diluent or carrier.
1 Assignment
0 Petitions
Accused Products
Abstract
There is provided a combination product comprising: (A) melagatran or a pharmaceutically-acceptable derivative thereof; and (B) a Factor VIIa inhibitor or a pharmaceutically-acceptable derivative thereof, wherein each of components (A) and (B) is formulated in admixture with a pharmaceutically-acceptable adjuvant, diluent or carrier, as well as the use of such a combination product in the treatment of a condition where anticoagulant therapy is indicated.
-
Citations
12 Claims
-
1. A combination product comprising:
-
(A) melagatran or a pharmaceutically-acceptable derivative thereof; and
(B) a Factor VIIa inhibitor or a pharmaceutically-acceptable derivative thereof, wherein each of components (A) and (B) is formulated in admixture with a pharmaceutically-acceptable adjuvant, diluent or carrier. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)
-
Specification